- $76.35m
- $123.94m
- $164.46m
- 57
- 96
- 13
- 56
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.57 | ||
| Price to Tang. Book | 1.18 | ||
| Price to Free Cashflow | 5.19 | ||
| Price to Sales | 0.46 | ||
| EV to EBITDA | 8.78 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 5.21% | ||
| Return on Equity | 4.87% | ||
| Operating Margin | 6.06% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 107.71 | 98.27 | 131.84 | 158.64 | 164.46 | 218.5 | n/a | 9.02% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -22.32 | n/a | n/a | +1766.74 | -0.83 | +106.9 | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Ultralife Corporation offers products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government, defense and commercial sectors. Its segments include Battery & Energy Products and Communications Systems. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, thin cell and other non-rechargeable batteries, in addition to rechargeable batteries, uninterruptable power supplies, charging systems and accessories. The Communications Systems segment includes RF amplifiers, power supplies, cable and connector assemblies, amplified speakers, equipment mounts, case equipment, man-portable systems, integrated communication systems for fixed or vehicle applications and communications and electronics systems design. Its brands include Ultralife, Ultralife HiRate, Lithium Power, McDowell Research, AMTI, ABLE, ACCUTRONICS, ACCUPRO, ENTELLION, SWE Southwest Electronic Energy Group, SWE SEASAFE, among others.
Directors
- Bradford Whitmore NEC (64)
- Michael Popielec CEO (59)
- Philip Fain CFO (66)
- Thomas Saeli IND (64)
- Robert Shaw IND (64)
- Ranjit Singh IND (68)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 14th, 1990
- Public Since
- December 23rd, 1992
- No. of Shareholders
- 5,700
- No. of Employees
- 671
- Sector
- Machinery, Equipment & Components
- Industry
- Industrials
- Exchange
NASDAQ Global Market- Shares in Issue
- 16,632,965
- Address
- 2000 Technology Pkwy, NEWARK, 14513-2175
- Web
- https://www.ultralifecorporation.com/
- Phone
- +1 3153327100
- Auditors
- Freed Maxick CPAs PC
Upcoming Events for ULBI
Q2 2025 Ultralife Corp Earnings Release
Similar to ULBI
Allient
NASDAQ Global Market
Blue Bird
NASDAQ Global Market
Eastern
NASDAQ Global Market
Elong Power Holding
NASDAQ Global Market
Frequency Electronics
NASDAQ Global Market
FAQ
What is the Ultralife share price?
As of Today at 23:50 UTC, shares in Ultralife are trading at $4.59. This share price information is delayed by 15 minutes.
How has the Ultralife share price performed this year?
Shares in Ultralife last closed at $4.59 and the price had moved by -57.14% over the past 365 days. In terms of relative price strength the Ultralife share price has underperformed the S&P500 Index by -60.44% over the past year.
What are the analyst and broker recommendations for Ultralife?
The overall consensus recommendation for Ultralife is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Ultralife dividend yield?
Ultralife does not currently pay a dividend.
Does Ultralife pay a dividend?
Ultralife does not currently pay a dividend.
When does Ultralife next pay dividends?
Ultralife does not currently pay a dividend.
How do I buy Ultralife shares?
To buy shares in Ultralife you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Ultralife?
As of the previous close price of $4.59, shares in Ultralife had a market capitalisation of $76.35m.
Where are Ultralife shares listed?
Here are the trading details for Ultralife:
- Country of listing: United States
- Exchange: NMQ
- Ticker Symbol: ULBI
What kind of share is Ultralife?
Based on an overall assessment of its quality, value and momentum Ultralife is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Ultralife share price forecast for 2025?
The analyst consensus target price for shares in Ultralife is $14.00. That is 205.01% above the last closing price of $4.59.
Analysts covering Ultralife currently have a consensus Earnings Per Share (EPS) forecast of $0.92 for the next financial year.
Find out moreWhat is the trend in the Ultralife share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Ultralife. Over the past six months, its share price has underperformed the S&P500 Index by -45.15%.
As of the last closing price of $4.59, shares in Ultralife were trading -43.07% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Ultralife PE Ratio?
The Ultralife PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $4.59.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Ultralife?
Ultralife's management team is headed by:
- Bradford Whitmore - NEC
- Michael Popielec - CEO
- Philip Fain - CFO
- Thomas Saeli - IND
- Robert Shaw - IND
- Ranjit Singh - IND